abiraterone has been researched along with edetic acid in 1 studies
Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (edetic acid) | Trials (edetic acid) | Recent Studies (post-2010) (edetic acid) |
---|---|---|---|---|---|
942 | 97 | 854 | 27,553 | 629 | 3,970 |
Protein | Taxonomy | abiraterone (IC50) | edetic acid (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 7.7 | |
Beta-lactamase VIM-1 | Pseudomonas aeruginosa | 9.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bundschuh, RA; Dolscheid-Pommerich, RC; Essler, M; Kristiansen, G; Kürpig, S; Mathy, CS; Mayr, T; Meisenheimer, M; Muders, MH; Stoffel-Wagner, B | 1 |
1 other study(ies) available for abiraterone and edetic acid
Article | Year |
---|---|
Antihormone treatment differentially regulates PSA secretion, PSMA expression and
Topics: Adenocarcinoma; Androgen Antagonists; Androstenes; Antigens, Surface; Cell Line, Tumor; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Humans; Male; Oligopeptides; PC-3 Cells; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Secretory Pathway | 2021 |